Switch theme
Sign up to access all valuation multiples
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
2018
6.3K+
LTM Revenue $2.8B
LTM EBITDA $10.8M
$313M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
YSB has a last 12-month revenue of $2.8B and a last 12-month EBITDA of $10.8M.
In the most recent fiscal year, YSB achieved revenue of $2.2B and an EBITDA of -$394M.
YSB expects next 12-month revenue of XXX and NTM EBITDA of XXX
See YSB valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.8B | $2.2B | XXX | XXX | XXX |
| Gross Profit | $118M | $185M | XXX | XXX | XXX |
| Gross Margin | 6% | 8% | XXX | XXX | XXX |
| EBITDA | -$174M | -$394M | XXX | XXX | XXX |
| EBITDA Margin | -9% | -18% | XXX | XXX | XXX |
| Net Profit | -$64.5M | -$193M | XXX | XXX | XXX |
| Net Margin | -4% | -9% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, YSB's stock price is HKD 6 (or $1).
YSB has current market cap of HKD 4.3B (or $553M), and EV of HKD 2.4B (or $313M).
See YSB trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $313M | $553M | XXX | XXX | XXX | XXX | $0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, YSB has market cap of $553M and EV of $313M.
YSB's trades at 0.1x LTM EV/Revenue multiple, and 31.1x LTM EBITDA.
Analysts estimate YSB's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for YSB and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $313M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | -0.8x | XXX | XXX | XXX |
| P/E | -1.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 5.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpYSB's NTM/LTM revenue growth is 14%
YSB's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $37K for the same period.
Over next 12 months, YSB's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate YSB's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for YSB and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -18% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 127% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -4% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $37K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 11% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
YSB acquired XXX companies to date.
Last acquisition by YSB was XXXXXXXX, XXXXX XXXXX XXXXXX . YSB acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was YSB founded? | YSB was founded in 2018. |
| Where is YSB headquartered? | YSB is headquartered in Hong Kong. |
| How many employees does YSB have? | As of today, YSB has 6.3K+ employees. |
| Who is the CEO of YSB? | YSB's CEO is Mr. Buzhen Zhang. |
| Is YSB publicy listed? | Yes, YSB is a public company listed on HKG. |
| What is the stock symbol of YSB? | YSB trades under 09885 ticker. |
| When did YSB go public? | YSB went public in 2023. |
| Who are competitors of YSB? | Similar companies to YSB include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of YSB? | YSB's current market cap is $553M |
| What is the current revenue of YSB? | YSB's last 12-month revenue is $2.8B. |
| What is the current EBITDA of YSB? | YSB's last 12-month EBITDA is $10.8M. |
| What is the current EV/Revenue multiple of YSB? | Current revenue multiple of YSB is 0.1x. |
| What is the current EV/EBITDA multiple of YSB? | Current EBITDA multiple of YSB is 31.1x. |
| What is the current revenue growth of YSB? | YSB revenue growth between 2023 and 2024 was 19%. |
| Is YSB profitable? | Yes, YSB is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
